Kathryn E Falberg's Net Worth
$101 Million
Who is Kathryn E Falberg?
Kathryn E Falberg has an estimated net worth of $101 Million. This is based on reported shares across multiple companies, which include Trade Desk, Inc., Nuvation Bio Inc., BIOMARIN PHARMACEUTICAL INC, Jazz Pharmaceuticals plc, Tricida, Inc., HALOZYME THERAPEUTICS INC, Arcus Biosciences, Inc., UroGen Pharma Ltd., QLT INC/BC, Axovant Sciences Ltd., aTYR PHARMA INC, ARCA biopharma, Inc., Aimmune Therapeutics, Inc., MEDIVATION, INC., and HUMAN GENOME SCIENCES INC.
SEC CIK
Kathryn E Falberg's CIK is 0001206977
Past Insider Trading and Trends
2019 was Kathryn E Falberg's most active year for acquiring shares with 16 total transactions. Kathryn E Falberg's most active month to acquire stocks was the month of April. 2020 was Kathryn E Falberg's most active year for disposing of shares, totalling 23 transactions. Kathryn E Falberg's most active month to dispose stocks was the month of October. 2015 saw Kathryn E Falberg paying a total of $3,341,684.00 for 74,181 shares, this is the most they've acquired in one year. In 2021 Kathryn E Falberg cashed out on 150,000 shares for a total of $16,288,480.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trade Desk, Inc. (TTD) Snapshot price: $68.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.77% | 4.3K |
$87.16 | $99,885.36 | 246.91K |
May 28
| |||
Form 4
|
—
|
0
|
$41.85 | -$8,252,437.61 | 242.61K |
Mar 8
| |||
Form 4
| +2.46% | 5.84K |
$62.52 | $99,906.96 | 242.61K |
May 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -0.01% | -21.00 |
$59.83 | -$1,256.43 | 236.75K |
Feb 6
| |||
Form 4
| +2.32% | 5.36K |
$59.83 | $70,898.55 | 236.77K |
May 26
| |||
Form 4
| -75.00% | -150.00K |
$108.59 | -$16,288,480.63 | 50K |
Nov 19
| |||
Form 4
| +18.93% | 500 |
$639.65 | $70,361.50 | 3.14K |
May 27
| |||
Form 4
|
—
|
0
|
$813.17 | -$16,263,340.42 | 2.64K |
Nov 19
| |||
Form 4
| +78.93% | 1.17K |
$249.66 | $65,910.24 | 2.64K |
May 26
| |||
Form 4
| -58.11% | -29.79K |
$207.02 | -$6,165,584.66 | 21.48K |
Nov 11
| |||
Form 4
| +14.35% | 1.48K |
$207.03 | $80,741.70 | 11.76K |
Apr 30
| |||
Form 4
| -66.67% | -40.00K |
$205.47 | -$8,218,964.00 | 20K |
Mar 11
| |||
Form 4
| -15.73% | -20.50K |
$134.83 | -$2,696,692.00 | 109.79K |
Sep 21 - Nov 28
| |||
Form 4
| +12.74% | 5.68K |
$49.44 | $80,982.72 | 50.29K |
May 3
| |||
Form 4
| +11.51% | 4.6K |
$54.52 | $70,985.04 | 44.6K |
Jul 20
| |||
Form 4
| +33.33% | 20K |
$48.06 | $961,154.00 | 80K |
Jun 15
| |||
Form 4
| +50.00% | 20K |
$43.38 | $867,664.00 | 60K |
Mar 1
| |||
Form 4
|
∞
| 80K |
$25.85 | $2,067,800.00 | 80K |
Nov 14 - Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nuvation Bio Inc. (NUVB) Snapshot price: $1.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 250K |
$1.94 | $483,835.81 | 250K |
Nov 30 - Dec 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $89.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 2.64K |
—
|
—
| 2.64K |
Jul 15
| |||
Form 4
|
∞
| 3.3K |
—
|
—
| 3.3K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.18
EVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.14% | -1.54K |
$157.60 | -$242,388.80 | 133.39K |
Mar 5
| |||
Form 4
| +8.18% | 10.2K |
$7.35 | $74,999.40 | 134.93K |
Feb 26
| |||
Form 4
| -1.58% | -2.00K |
$157.00 | -$314,000.00 | 124.72K |
Scheduled
|
Feb 12
| ||
Form 4
| -1.55% | -2.00K |
$131.82 | -$263,640.00 | 126.72K |
Scheduled
|
Jan 8
| ||
Form 4
| -2.28% | -3.00K |
$120.50 | -$361,500.00 | 128.72K |
Scheduled
|
Dec 11
| ||
Form 4
| -2.23% | -3.00K |
$100.88 | -$302,640.00 | 131.37K |
Scheduled
|
Nov 13
| ||
Form 4
| -2.18% | -3.00K |
$83.10 | -$249,300.00 | 134.37K |
Scheduled
|
Oct 9
| ||
Form 4
| -2.14% | -3.00K |
$87.52 | -$262,560.00 | 137.37K |
Scheduled
|
Sep 11
| ||
Form 4
| -2.09% | -3.00K |
$81.02 | -$243,060.00 | 140.37K |
Scheduled
|
Aug 14
| ||
Form 4
| -2.36% | -3.46K |
$80.88 | -$280,168.32 | 143.37K |
Aug 9
| |||
Form 4
| -2.00% | -3.00K |
$72.40 | -$217,200.00 | 146.84K |
Scheduled
|
Jul 10
| ||
Form 4
| +11.99% | 16K |
—
|
—
| 149.42K |
Mar 5
| |||
Form 4
| +49.57% | 44.22K |
$7.35 | $324,987.60 | 133.42K |
Mar 5
| |||
Form 4
| -40.33% | -60.00K |
$47.53 | -$2,853,570.00 | 88.78K |
Aug 16
| |||
Form 4
| +57.58% | 35K |
—
|
—
| 95.78K |
Aug 9
| |||
Form 4
| +4.43% | 2.58K |
$6.43 | $16,595.83 | 60.78K |
May 31
| |||
Form 4
|
∞
| 111.2K |
—
|
—
| 111.2K |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -111.20K |
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +1,597.81% | 54.77K |
$31.63 | -$2,151,807.20 | 58.2K |
Jan 11
| |||
Form 4
| +221.88% | 2.36K |
$6.43 | $15,194.09 | 3.43K |
Nov 30
| |||
Form 4
| +6.00% | 3K |
$37.36 | $112,080.00 | 53K |
Nov 11
| |||
Form 4
| +81.74% | 479 |
$6.43 | $3,079.97 | 1.06K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
∞
| 586 |
$6.43 | $3,767.98 | 586 |
Nov 30
| |||
Form 4
|
∞
| 50K |
$8.72 | $436,224.40 | 50K |
Aug 30 - Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tricida, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +38.36% | 16.4K |
—
|
—
| 59.16K |
Jun 10
| |||
Form 4
| +15.29% | 5.67K |
—
|
—
| 42.76K |
Jun 11
| |||
Form 4
| +5.34% | 1.88K |
—
|
—
| 37.09K |
May 31
| |||
Form 4
|
∞
| 35.21K |
$19.00 | $600,001.00 | 35.21K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||